AVI BioPharma, Inc. Completes Registered Direct Offering, Raises $20.3 Million

PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (NASDAQ: AVII) has successfully completed its previously announced registered direct offering consistent with the terms and conditions announced in AVI BioPharma’s December 12, 2007 press release.